Avastin recalled over sterility concerns

Recall date

June 19, 2019

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Official notice title

RXQ Compounding LLC recalls Avastin, 25MG/ML Syringe, [a) 0.1 mL NDC 70731-0197-91; b) 0.12 mL NDC 70731-0197-92; c) 0.15 mL NDC 70731-0197-93] per…

Recall number

D-1637-2019

FDA classification

Class II

Brand / firm

RXQ Compounding LLC

Sold / distributed

Nationwide USA

Why it was recalled

Lack of Assurance of Sterility

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Avastin, 25MG/ML Syringe, [a) 0.1 mL NDC 70731-0197-91; b) 0.12 mL NDC 70731-0197-92; c) 0.15 mL NDC 70731-0197-93] per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.